StreetInsider.com News Articles

Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

Mon, 24 Aug 2026 08:00:00 -0400

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –

BOULDER, Colo., Aug. 24, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases, today announced that the CIRRUS-HCM abstract was selected for a late-breaking science presentation at the European Society of Cardiology (ESC) Congress, taking place August 28-31 in Munich, Germany. EDG-7500 is a novel, oral, selective cardiac sarcomere modulator designed to slow early contraction and improve cardiac relaxation

Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

Mon, 24 Aug 2026 08:00:00 -0400

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –

Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

Mon, 24 Aug 2026 08:00:00 -0400

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –

Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

Mon, 24 Aug 2026 08:00:00 -0400

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –

Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

Mon, 24 Aug 2026 08:00:00 -0400

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –

Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

Mon, 24 Aug 2026 08:00:00 -0400

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –

Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

Mon, 24 Aug 2026 08:00:00 -0400

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –

Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026

Mon, 24 Aug 2026 08:00:00 -0400

– Presentation highlights positive top-line data from 12-week Phase 2 CIRRUS-HCM trial with EDG-7500 in obstructive and nonobstructive hypertrophic cardiomyopathy (HCM) –

Edgewise Therapeutics (EWTX) PT Raised to $60 at JPMorgan

Thu, 20 Aug 2026 09:07:48 -0400

JPMorgan analyst Tessa Romero raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $60.00 (from $53.00) while maintaining a Overweight rating.

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: Nofi Michael

Mon, 17 Aug 2026 18:42:00 -0400

si-local-file:///var/storage/secattach/20260817/26939216.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: Nofi Michael

Mon, 17 Aug 2026 18:42:00 -0400

si-local-file:///var/storage/secattach/20260817/26939216.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: Russell Alan J

Mon, 17 Aug 2026 18:41:00 -0400

si-local-file:///var/storage/secattach/20260817/26939213.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: Russell Alan J

Mon, 17 Aug 2026 18:41:00 -0400

si-local-file:///var/storage/secattach/20260817/26939213.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: Donovan Joanne M.

Mon, 17 Aug 2026 18:41:00 -0400

si-local-file:///var/storage/secattach/20260817/26939214.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: Donovan Joanne M.

Mon, 17 Aug 2026 18:41:00 -0400

si-local-file:///var/storage/secattach/20260817/26939214.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: Derakhshan Behrad

Mon, 17 Aug 2026 18:40:00 -0400

si-local-file:///var/storage/secattach/20260817/26939211.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: Derakhshan Behrad

Mon, 17 Aug 2026 18:40:00 -0400

si-local-file:///var/storage/secattach/20260817/26939211.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: MOORE JOHN R

Mon, 17 Aug 2026 18:40:00 -0400

si-local-file:///var/storage/secattach/20260817/26939212.html

Form 4/A Edgewise Therapeutics, For: Aug 12 Filed by: MOORE JOHN R

Mon, 17 Aug 2026 18:40:00 -0400

si-local-file:///var/storage/secattach/20260817/26939212.html

Form 4 Edgewise Therapeutics, For: Aug 12 Filed by: Nofi Michael

Fri, 14 Aug 2026 16:55:00 -0400

si-local-file:///var/storage/secattach/20260814/26932284.html

Form 4 Edgewise Therapeutics, For: Aug 12 Filed by: Nofi Michael

Fri, 14 Aug 2026 16:55:00 -0400

si-local-file:///var/storage/secattach/20260814/26932284.html

Form 4 Edgewise Therapeutics, For: Aug 12 Filed by: Russell Alan J

Fri, 14 Aug 2026 16:54:00 -0400

si-local-file:///var/storage/secattach/20260814/26932270.html

Form 4 Edgewise Therapeutics, For: Aug 12 Filed by: Russell Alan J

Fri, 14 Aug 2026 16:54:00 -0400

si-local-file:///var/storage/secattach/20260814/26932270.html

Form 4 Edgewise Therapeutics, For: Aug 12 Filed by: Donovan Joanne M.

Fri, 14 Aug 2026 16:54:00 -0400

si-local-file:///var/storage/secattach/20260814/26932271.html

Form 4 Edgewise Therapeutics, For: Aug 12 Filed by: Donovan Joanne M.

Fri, 14 Aug 2026 16:54:00 -0400

si-local-file:///var/storage/secattach/20260814/26932271.html